Bibliographic Details
| Title: |
The Impact of Sedation on Cardio-Cerebrovascular Adverse Events after Surveillance Esophagogastroduodenoscopy in Patients with Gastric Cancer: A Nationwide Population-Based Cohort Study |
| Authors: |
Sang Yoon Kim, Jun Kyu Lee, Kwang Hyuck Lee, Jae-Young Jang, Byung-Wook Kim, Endoscopic Sedation Committee of Korean Society of Gastrointestinal Endoscopy (KSGE) |
| Source: |
Gut and Liver, Vol 18, Iss 2, Pp 245-256 (2024) |
| Publisher Information: |
Gastroenterology Council for Gut and Liver, 2024. |
| Publication Year: |
2024 |
| Collection: |
LCC:Diseases of the digestive system. Gastroenterology |
| Subject Terms: |
adverse events, stomach neoplasms, esophagogastroduodenoscopy, sedatives, Diseases of the digestive system. Gastroenterology, RC799-869 |
| More Details: |
Background/Aims: The impact of sedation on cardio-cerebrovascular (CCV) adverse events after esophagogastroduodenoscopy (EGD) in patients with gastric cancer (GC) is unclear. We investigated the incidence rate and impact of sedation on CCV adverse events after surveillance EGD in patients with GC. Methods : We performed a nationwide population-based cohort study using the Health Insurance Review and Assessment Service databases from January 1, 2018, to December 31, 2020. Using a propensity score-matched analysis, patients with GC were divided into two groups: sedative agent users and nonusers for surveillance EGD. We compared the occurrence of CCV adverse events within 14 days between the two groups. Results : Of the 103,463 patients with GC, newly diagnosed CCV adverse events occurred in 2.57% of patients within 14 days after surveillance EGD. Sedative agents were used in 41.3% of the patients during EGD. The incidence rates of CCV adverse events with and without sedation were 173.6/10,000 and 315.4/10,000, respectively. Between sedative agent users and nonusers based on propensity score matching (28,008 pairs), there were no significant differences in the occurrence of 14-day CCV, cardiac, cerebral, and other vascular adverse events (2.28% vs 2.22%, p=0.69; 1.44% vs 1.31%, p=0.23; 0.74% vs 0.84%, p=0.20; 0.10% vs 0.07%, p=0.25, respectively). Conclusion : s: Sedation during surveillance EGD was not associated with CCV adverse events in patients with GC. Therefore, the use of sedative agents may be considered in patients with GC during surveillance EGD without excessive concerns about CCV adverse events. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
1976-2283 |
| Relation: |
http://gutnliver.org/journal/view.html?doi=10.5009/gnl230043; https://doaj.org/toc/1976-2283 |
| DOI: |
10.5009/gnl230043 |
| Access URL: |
https://doaj.org/article/11c2072ffc324d5b82d7803758d77008 |
| Accession Number: |
edsdoj.11c2072ffc324d5b82d7803758d77008 |
| Database: |
Directory of Open Access Journals |
